How does lebrikizumab impact the quality of life in patients with moderate to severe atopic dermatitis?
Featuring Raj Chovatiya, MD, PhD, MSCI | Associate Professor, Rosalind Franklin University of Medicine and Science, Chicago Medical School; Founder and Director,Center for Medical Dermatology + Immunology Research,Chicago, IL | Published December 02, 2024
Related Media
Powered by Polaris TM